Clinical trial Recruiting at 1 site Interventional Ages 16 to 60

Epidural electrical stimulation for restoring motor and sensory function after chronic spinal cord injury

Official title: Epidural Electrical Stimulation for Motor and Sensory Function Reconstruction in Spinal Cord Injury

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07105878 · Data updated 2026-11-12

This will try epidural electrical stimulation to see if it helps people with chronic spinal cord injuries (ASIA B–D) regain motor and sensory function.

Quick facts

Study typeInterventional
Ages16 Years to 60 Years
SexAll
Enrollment10 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedApril 24, 2026
Trial IDNCT07105878 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with chronic spinal cord injury 8–36 months after injury, ASIA impairment scale B–D, injury above T10, limited improvement after rehabilitation, and a WISCI II score below 13.

Probably not a fit

Patients with injuries outside the 8–36 month window, injuries at or below T10, severe other neurological or psychiatric disorders, coagulation dysfunction, or active substance dependence may not benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants will undergo surgical implantation of an epidural electrical stimulation (EES) device with device activation and personalized stimulation adjustments during follow-up. Motor and sensory function, plus quality of life, will be measured before implantation, immediately after activation, and at 1, 3, and 6 months post-implantation. The protocol includes standard rehabilitation and objective testing such as PET-CT, diffusion tensor imaging (DTI), and somatosensory evoked potentials (SEPs) to track physiological changes. Eligible patients are chronic SCI cases (8–36 months post-injury) with ASIA B–D and injury level above T10.

Why it matters

Potential benefit: If successful, EES could restore some voluntary movement and sensation and improve independence and quality of life for people with chronic SCI.

How similar studies have gone: Prior case series and small trials of epidural stimulation have produced notable voluntary movement and functional gains in some patients, but larger controlled evidence remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Spinal Cord Injury, ASIA B-D;
* Spinal cord injury level above T10;
* Diagnosed with spinal cord injury for ≥ 8 months and ≤ 36 months;
* WISCI II score \< 13;
* No significant improvement in motor dysfunction after rehabitation over the past 2 months.
* An expected survival period of ≥ 12 months.
* Subjects voluntarily participate in this study, sign the informed consent form, have good compliance, cooperate with necessary postoperative rehabilitation training and tests, and assist in follow-up visits.

Exclusion Criteria:

* Subjects with other severe organic neurological diseases, mental illnesses other than anxiety/depression.
* Subjects with hemorrhagic diathesis or coagulation dysfunction (prothrombin time \[PT\] ≥ 18 seconds).
* Subjects with a history of alcohol or drug abuse or dependence.
* Subjects with mental retardation, cognitive dysfunction, or personality disorders.
* Subjects with a history of electroconvulsive therapy or those requiring continuous electrotherapy.
* Subjects with implanted cardiac pacemakers, cardioverters, or defibrillators. Expected survival period \< 1 year.

Where it's running

  • Second Affiliated Hospital, School of Medicine, Zhejiang University
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: Junming Zhu, Chief Physician — Second Affiliated Hospital, Zhejiang University, School of Medicine
  • Study coordinator: Junming Zhu, Chief Physician
  • Email: dr.zhujunming@zju.edu.cn
  • Phone: 13968055768

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.